This is in reference to the 'Outcome of the Meeting of Board of Directors' dated January 20, 2026, we wish to inform you that the Board of Directors of Dr Lalchandani Labs Limited, at its ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
The Board of Directors of Dr Lalchandani Labs Limited, at its meeting on February 16, 2026, approved an extension of the closing date of the company's ongoing Rights Issue. The issue, which opened on February 4, 2026 and was originally scheduled to close on February 20, 2026, will now close on February 27, 2026 — a 7-day extension. The company stated the extension was granted to allow better participation from eligible shareholders. The revised timeline includes the last date for renunciation of rights entitlements as February 24, 2026, with basis of allotment and date of allotment expected on or about March 2, 2026, and listing on or about March 5, 2026. No other changes have been made to the Letter of Offer or related documents.
The extended timeline gives existing shareholders more time to participate in the rights issue, which could help improve subscription levels. Investors should watch for subscription response at the new closing date; weak response could pressure the stock, while strong demand may signal confidence in the fundraise.